Position in VTRS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$400,048
+$43,033 QoQ
Shares Held
25,192
-4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#446
of 1,022 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $5,825,413 across 37 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
25,052 | $1,800,236 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
81,864 | $1,186,209 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,130 | $612,267 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
28,293 | $453,536 | |
| 5 | VTRS |
Viatris Inc
This page
|
25,192 | $400,048 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,719 | $289,720 | |
| 7 | PRGO |
PERRIGO Co plc
|
16,056 | $166,821 | |
| 8 | HLN |
Haleon plc
|
16,900 | $157,677 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $400,048 | 25,192 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $357,015 | 26,426 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $312,943 | 25,136 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $218,968 | 22,118 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $192,923 | 21,604 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $190,034 | 21,818 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $357,651 | 28,727 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $309,557 | 26,663 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $259,095 | 24,374 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $216,806 | 18,158 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $194,918 | 17,998 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $389,864 | 39,540 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $398,830 | 39,963 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $330,937 | 34,401 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $91,900 | 8,257 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $65,731 | 7,715 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $56,213 | 5,369 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $36,371 | 3,343 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $88,756 | 6,560 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $126,123 | 9,308 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $192,086 | 13,442 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $250,007 | 17,896 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $424,966 | 22,677 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||